1. In a cohort of more than 900 low-risk prostate cancer patients followed for up to 15 years, 2.8% of patients developed metastatic disease and 1.5% died of prostate cancer. 

2. The relative likelihood of dying from other causes compared to dying from prostate cancer death in this cohort was 9.2 to 1. 

Evidence Rating Level: 2 (Good)


Continue Reading

Study Rundown: Prostate cancer is the most common malignancies in men, with a lifetime risk of 1 in 7. Active surveillance (AS) is the process of forgoing initial definitive treatment for delayed definitive intervention when specific signs of disease progression has occurred.

READ FULL ARTICLE Curated publisher From 2minutemedicine